
This content was machine translated.
About Climedo
Climedo offers an integrated eCOA and EDC solution with hybrid capabilities for non-interventional studies and real-world evidence. With its patient-centric approach and continuous delivery of data insights and visualizations on current study progress, Climedo enables its customers to communicate better with healthcare professionals and other key opinion leaders (KOLs). This increases transparency, stimulates scientific dialogue, and accelerates the launch success of new medical innovations, enabling more patients to be reached faster. Climedo was founded in Munich in 2017 and is a leading partner for pharma, medical device, CROs, and academic institutions with over 1.7 million enrolled patients.
More like this
